Resultado da Busca
23 de mai. de 2024 · The Technical University of Darmstadt is a synonym for excellent, relevant science. Excellence Strategy. June 04, 2024. Making AI models plausible. The LOEWE focus area “WhiteBox” Picture: Patrick Bal. May 29, 2024. On the trail of human cognition. Pragmatic AI for less bias. May 23, 2024. Significant contributions to life science engineering.
- Overview of All Departments
TU Darmstadt incorporates diverse science cultures to create...
- Deutschlandstipendium
Application and granting process. Here you will find...
- Studying at TU Darmstadt
Studying at TU Darmstadt? A very good choice. A decision for...
- Legal Note
Umsatzsteuer-Identifikations-Nummer: DE 111 608 628....
- Overview of All Departments
27 de mai. de 2024 · Stay up to date with the latest news and events at TU Delft. Learn about cutting-edge research and inspiring stories that are shaping our community and impacting the world.
16 de mai. de 2024 · Did you know that solar cells typically convert only 20% of the sunlight into electrical power? That means that 80% is not utilised, leaving a large room for improvement for next generation solar cells. Researchers from Delft University of Technology developed a method to find new materials for more efficient solar cells.
14 de mai. de 2024 · É o que explica Taneha Bacchin, professora em projeto urbano da Universidade Técnica de Delft, na Holanda, em entrevista ao podcast O Assunto desta terça-feira (14).
24 de mai. de 2024 · A team of researchers at Delft University of Technology has developed a drone that flies autonomously using neuromorphic image processing and control based on the workings of animal brains. Animal brains use less data and energy compared to current deep neural networks running on GPUs (graphic chips).
14 de mai. de 2024 · Para discutir a adaptação do espaço urbano, Natuza Nery recebe a arquiteta e urbanista Taneha Bacchin, professora em projeto urbano da Universidade Técnica de Delft, na Holanda.
23 de mai. de 2024 · Research. Cancer treatments often struggle with balancing efficacy and side effects. A new study by EPFL scientists offers a promising solution using antibody-peptide inhibitor conjugates to target specific cell types and block the activity of cancer-promoting enzymes called cathepsins. Read more.
